Fragile X Syndrome Research Study

Children Are Our Commitment

Learn more about a clinical trial evaluating investigational cannabidiol (CBD) gel to see if it helps behavioral issues related to Fragile X syndrome.

Qualified participants are:

  • Between 3 and 17 years of age
  • Diagnosed via genetic testing, with Fragile X syndrome
  • In generally good health 

Apply to Participate